Medical Devices · Healthcare
Board Member
2025-01-01–present
Board Member
Pacific Biosciences Of California, Inc. (PACB)Equibles does not estimate personal net worth.
Get an email with a short summary when Pacific Biosciences Of California, Inc. publishes a filing, an earnings call transcript or a press release.
Get PACB alertsChristopher M. Smith is recorded as Board Member at Pacific Biosciences Of California, Inc. (PACB) since June 3, 2026. Earlier roles on record: Board Member at QuidelOrtho Corp (QDEL) until August 31, 2023. Pacific Biosciences Of California, Inc. reported in an 8-K filed July 9, 2026 that Christopher M. Smith resigned as member of the board of directors, effective July 8, 2026. The same filing states: “The Company is not aware of any disagreement between Mr. Smith and the Company on any matter relating to the Company’s operations, policies or practices that resulted in Mr. Smith’s resignation.” Pacific Biosciences Of California, Inc. reported in an 8-K filed June 4, 2026 that Christopher M. Smith was appointed Class III Director, effective June 3, 2026. Pacific Biosciences Of California, Inc. reported in an 8-K filed June 6, 2025 that Christopher M. Smith was appointed Class III Director, effective June 4, 2025. Equibles holds 5 filed executive changes naming Christopher M. Smith; each is listed under recent activity with its source filing. Pacific Biosciences Of California, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Pacific Biosciences Of California, Inc. includes Christian Henry (CEO, CFO and Board Member), Mark Van Oene (CEO, CFO, COO and Board Member), Christian O. Henry (Chairman and Board Member) and 7 others.
“On July 8, 2026, Christopher M. Smith, a member of the board of directors (the "Board") of Pacific Biosciences of California, Inc. (the "Company"), notified the Company of his resignation from the Board, effective immediately.”
“The Company is not aware of any disagreement between Mr. Smith and the Company on any matter relating to the Company’s operations, policies or practices that resulted in Mr. Smith’s resignation.”
“Each director nominee was duly elected to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier resignation or removal.”
2026-06-03–present
2025-01-01–2026-07-08
Start not stated–2023-08-31
Medical Devices · Healthcare
Board Member
2025-01-01–present
“The Company is not aware of any disagreement between Mr. Smith and the Company on any matter relating to the Company’s operations, policies or practices that resulted in Mr. Smith’s resignation.”
Pacific Biosciences Of California, Inc. (PACB)